Defiance Nasdaq Junior Biotechnology ETF (IBBJ)
Defiance Nasdaq Junior Biotechnology ETF (IBBJ) reported 232 holdings in its SEC Form NPORT-P for the period ended 2021-09-30.
No stock price history for IBBJ on this site yet.
SEC Form NPORT-P as filed (series S000064808), accession 0001145549-21-072046.
Similar ETFs
| ETF Name | Country | Net Assets | Overlap |
|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF (XBI) | United States | $7.434B | 23.73% |
| Principal Healthcare Innovators ETF (BTEC) | 22.83% | ||
| Direxion Daily S&P Biotech Bull 3X Shares (LABU) | United States | $0.519B | 22.65% |
| ProShares UltraPro Nasdaq Biotechnology (UBIO) | 17.93% | ||
| Invesco Nasdaq Biotechnology ETF (IBBQ) | United States | $0.076B | 16.56% |
| Virtus Biotech Etf (BBP) | United States | $0.059B | 16.43% |
| Virtus Biotech Clinical Trials Etf (BBC) | United States | $0.037B | 15.97% |
| iShares Biotechnology ETF (IBB) | United States | $8.123B | 15.68% |
| Range Cancer Therapeutics ETF (CNCR) | 15.10% | ||
| WisdomTree BioRevolution Fund (WDNA) | United States | $0.002B | 14.65% |